Researchers have uncovered a critical, previously underappreciated role for B cells in vaccine protection. Best known for producing antibodies, B cells also guide other immune cells, specifically CD8 ...

Researchers have discovered a previously unknown type of connective tissue cells that surround cancer cells in pancreatic tumors. The newly discovered cells counteract tumor development and may ...

Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a ...

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

Innovative polatuzumab vedotin plus R-CHP therapy reshapes treatment of older adult patients with diffuse large B-cell lymphoma.

Find out how Gylden Pharma’s gold nanoparticle platform delivers targeted T cell immunity – providing a precise and durable defence against complex infectious diseases. In the fast-moving world of ...

That would mean the deportees’ heads have been shaved and they are kept in communal cells holding up to 100 men each for 23½ hours a day. Two sources told CNN the situation is less regimented ...

PRESENTED at EBMT 2025 Annual Meeting, a new study explored the long-term effectiveness of chimeric antigen receptor (CAR)-T cell cocktail therapy for patients with relapsed/refractory diffuse large B ...

B-ALL/NHL 2002 protocol achieved a 3-year overall survival and progression-free survival of 73% in adult patients with Burkitt lymphoma/leukemia (BL). While demonstrating efficacy comparable with ...

Results of a phase 1 trial (NCT04074746) evaluating the combination of the bispecific antibody AFM13 and expanded natural killer (NK) cells precomplexed with AFM13 (AFM13-NK) in 42 patients with ...

These findings suggest this unique cell therapy approach has promise for specific patients with lymphoma, but it may be adapted for more cancer types in the future. "We observed rapid and strong ...

For this purpose, we fused the PE38 toxin with the specific C5 sdAb antibody, previously developed by our group for canine B-cell lymphoma. This resulted in a stable and highly specific C5-PE38 ...